🚨 BREAKING News from Clival Database!| WEEK 5 | 28th July 2026 🚨 Obesity Breakthrough? Ascletis’ ASC37 Delivers Strong Weight Loss Results 🔹 Ascletis’ once-monthly subcutaneously administered GLP-1R/GIPR/GCGR triple peptide agonist, ASC37, demonstrated superior weight loss in a diet-induced obese mouse model 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
About us
Clival database is a clinical trials-based platform that offers insights into over 500,000 clinical trials and innovative drugs for the pharmaceutical and allied industries. These insights cover details pertaining to clinical trial development phases from phase 0 to phase 4 data and statistics from all the regulatory markets including but not limited to the United States, European Union, Australia, New Zealand, Japan, Canada, and we specifically focus on collecting data from emerging regulatory markets such as India. The database is designed to help users by providing them with access to clinical trial data and insights on different specifications such as products/candidates, therapeutic area indications, sponsors/organizations, etc. Dive into a meticulously curated databank offered to you, which covers: - A. Company Analysis/ Pipeline Analysis B. Safety & Efficacy Data C. Product level analysis D. Reason for termination/ discontinuation/ suspension E. Patent insight on approved molecules F. Historical sales data of approved molecules G. Newsletter platform for competitors H. Primary molecule identification I. Licensing availability J. Biological Subtype K. Therapeutic area-based analysis L. NDA/sNDA module M. Prediction of launch N. Highest development phase O. Deals/ Collaborations P. ODD/ FTA/ BTA status of approved molecules Q. PI contact details
- Website
-
https://clival.com/
External link for Clival Database
- Industry
- Market Research
- Company size
- 51-200 employees
- Headquarters
- Noida, UP
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Clinical Trial Database
Locations
-
Primary
Get directions
C-89
Sector-65
Noida, UP 201301, IN
-
Get directions
C-89
Sector - 65
Noida, UP 201301, IN
Employees at Clival Database
Updates
-
🚨 BREAKING News from Clival Database!| WEEK 5 | 27th July 2026 🚨 NewAmsterdam Pharma & Menarini Reach Major EU Regulatory Milestone 🔹 NewAmsterdam Pharma and the Menarini Group have received a positive opinion from the CHMP recommending marketing authorization for Ubeslo® (obicetrapib monotherapy) and Evlarco® (fixed-dose combination of obicetrapib and ezetimibe). 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
-
🚨 BREAKING News from Clival Database!| WEEK 4 | 25th July 2026 🚨 Arrowhead Scores Phase 3 Success in Severe Hypertriglyceridemia Trial 🔹 Arrowhead Pharma announces positive results from phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in patients with severe hypertriglyceridemia 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
-
🚨 BREAKING News from Clival Database!| WEEK 4 | 22th July 2026 🚨 AIDS 2026: ViiV Showcases Dovato, Biktarvy & Long-Acting HIV Innovation 🔹 ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
-
🚨 BREAKING News from Clival Database!| WEEK 4 | 21th July 2026 🚨 Clinical Update: Armata Reports Key Progress for AP-SA02 Program 🔹 Armata Pharma achieves key progress across clinical, regulatory and manufacturing activities supporting planned phase 3 initiation of AP-SA02 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
-
🚨 BREAKING News from Clival Database!| WEEK 4 | 20th July 2026 🚨 Insmed Shows Strong 12-Month Results | GSK Shares Phase 3 Trial Update 🔹 Insmed reports positive 12-month data from ongoing OLE extension study of treprostinil palmitil inhalation powder in patients with pulmonary arterial hypertension 🔹 GSK provides an update on CALM-1 and CALM-2 phase III trials for camlipixant in refractory chronic cough 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
-
🚨 BREAKING News from Clival Database!| WEEK 3 | 17th July 2026 🚨 Clinical Update: Boehringer Begins Phase 2 | Atea Starts Phase 1 for Hepatitis E 🔹 Boehringer Ingelheim begins phase II trial of triple GLP-1/GIP/NPY2 receptor agonist, BI 3034701 in patients with obesity and overweight 🔹 Atea Pharma initiates first-in-human phase 1 trial of AT-587 for the treatment of hepatitis E virus 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 . . . #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
-
🚨 BREAKING News from Clival Database!| WEEK 3 | 16th July 2026 🚨 Clinical Update: Lingke Completes Enrollment | Atrium Secures FDA IND Approval 🔹 Lingke Pharmaceuticals completes patient enrolment in phase III trial of zaprixitinib for the treatment of ankylosing spondylitis 🔹 US FDA clears Atrium Therapeutics’ IND application for ATR 1072 to treat of PRKAG2 syndrome 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 . . . #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
-
🚨 BREAKING News from Clival Database!| WEEK 3 | 13th July 2026 🚨 Pharma Trial News: Novo Nordisk Phase 3 Success & OKYO’s FDA Milestone 🚀 🔹 Novo Nordisk presents positive results from phase 3 FRONTIER4 extension study of denecimig subcutaneous prophylaxis in children, adolescents, and adults with haemophilia A at ISTH 2026 🔹 OKYO Pharma announces positive feedback from US FDA Type D Meeting and accelerates urcosimod into global phase 3 trial for NCP 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 . . . #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia
-
🚨 BREAKING News from Clival Database!| WEEK 2 | 11th July 2026 🚨 Pharma Trial News: Lynk Begins Phase 2 | Keenova Achieves Phase 3 Milestone 🚀 🔹 Lynk Pharmaceuticals doses first patient in phase II trial of LNK01004 ointment for vitiligo 🔹 Keenova Therapeutics announces positive results from phase 3 trial of Xiaflex for the treatment of plantar fibromatosis 🚀 These breakthroughs highlight how innovation, advanced clinical strategies, and global expansion are reshaping the future of healthcare and patient outcomes. 🎥 Watch complete analysis & expert insights on our YouTube channel: 👉 https://lnkd.in/g655VA-J 📰 Explore more verified clinical and pharma updates anytime: 👉 https://clival.com/news 📊 Want deeper clinical intelligence, pipeline tracking, competitor benchmarking, and real-time pharma insights? 📅 Book a demo with Clival Database today: 👉 https://lnkd.in/dSdbxTJF 📡 Daily updates. Verified insights. Real-time research breakthroughs — only on Clival Database. 🌐 Visit: www.clival.com 📞 Toll-Free: 1800 4190 155 #Clival #ClivalDatabase #ClinicalResearch #PharmaNews #BiotechNews #ClinicalTrials #MedicalResearch #PharmaInnovation #BiotechInnovation #LifeSciences #DrugDevelopment #HealthcareInnovation #PharmaTrends #LifeScienceIntellipedia